Caribou Biosciences
CRBU55
$1.02arrow_drop_down6.39%-$0.07
Penny Stock
CRBU55
$1.02
arrow_drop_down6.39%| Key Stats | |
|---|---|
| Open | $1.05 |
| Prev. Close | $1.09 |
| EPS | -1.66 |
| Dividend | Non-Dividend |
| Next Earnings Date | - |
| Dividend Yield % | - |
| Market Cap | $78.11M |
| PE Ratio | - |
| LOW | HIGH | |
|---|---|---|
| Day Range | 1.02 | 1.16 |
| 52 Week Range | 0.71 | 8.33 |
| Ratios | |
|---|---|
| EPS | -1.66 |
| Fundamentals | |
|---|---|
| Gross Profit | - |
| Payout Ratio | - |
| Industry average yield | 2.89% |
| Last Dividend pay date | - |
| Dividend per share | - |
| Dividend yield forecast | - |
Stock Analysis
Technicals
Summarizing what the indicators are suggesting.
—Strong Buy
—Buy
—Neutral
—Sell
—Strong Sell
Analyst rating
An aggregate view of professional's ratings.
—Strong Buy
—Buy
—Neutral
—Sell
—Strong Sell
Stock Performance
CRBU-
US Healthcare Sector-
US Market-
warning
CRBU / Market
CRBU lose to the US Market which returned 0.03% over the last twenty four hours.warning
CRBU / Healthcare Sector
CRBU lose to the US Healthcare sector which returned 2.60% over the last twenty four hours.Caribou Biosciences (CRBU) Statistics
Keep an eye on Caribou Biosciences
Adding the right stocks to your watchlist can provide valuable insights and opportunities for strategic decision-making.
Frequently Asked Questions
help
How much debt does Caribou Biosciences (CRBU) have?
Caribou Biosciences (CRBU) has a total debt of $26.64M. The net debt, which accounts for cash and cash equivalents against the total debt, is -$5.33M.
help
What is the operating margin of Caribou Biosciences (CRBU) stock?
The operating margin for Caribou Biosciences (CRBU) is -1.67K%. This metric represents the percentage of revenue that remains after paying for variable production costs, indicating the efficiency and profitability of the company's core business operations.
help
What is the EBITDA of Caribou Biosciences (CRBU) stock?
The EBITDA (Earnings Before Interest, Taxes, Depreciation, and Amortization) of Caribou Biosciences (CRBU) is -$157.8M. EBITDA is a widely used earnings metric to assess a company's operational efficiency and profitability before the impact of non-operating decisions such as financing, accounting, and tax environments.
help
How has Caribou Biosciences (CRBU) stock's performance compared to its sector and the market over the past year?
Over the past year, Caribou Biosciences (CRBU) has experienced a price change of . Compared to the Healthcare sector, which saw a change of 15.12%, Caribou Biosciences has underperformed compared to its sector, indicating its relative standing within the Healthcare sector. Against the broader market's change of 23.87%, it has fallen short of the market average. This comparison highlights Caribou Biosciences's performance relative to both its sector and the overall market over the last year.
help
What is the PE ratio of Caribou Biosciences (CRBU) stock?
The PE ratio for Caribou Biosciences (CRBU) is currently not available. This could be due to a variety of factors such as the company not having positive earnings at the moment or recent updates not being reflected.
help
What is the EPS of Caribou Biosciences (CRBU) stock?
The Earnings Per Share (EPS) for Caribou Biosciences (CRBU), calculated on a diluted basis, is -$1.66. EPS is a key indicator of a company's profitability, showing the portion of a company's profit allocated to each outstanding share of common stock.